Clot-busting drugs prevent 4,000 strokes each year

July 9, 2018, University of Leeds

An increased use of clot-busting medicines prevented 4,000 strokes in England between 2015 and 2016, according to new research.

The drugs were given to patients who were suffering from an called atrial fibrillation (AF) which can result in a five-fold increased risk of a , compared to people who do not have the condition.

But the study, conducted by researchers at the University of Leeds, estimated there are half a million people living with undiagnosed AF.

Chris Gale, Professor of Cardiovascular Medicine and Consultant Cardiologist who supervised the study, said: "Sudden strokes in people who have AF are unnecessarily common. Treatments which prevent AF-related strokes are saving lives, but there are still many thousands of people in the UK living with undiagnosed AF who are missing out.

"The risk of AF rises dramatically with age. Our ageing population makes it clear that without intervention, cases of AF and associated strokes are only going to increase.

"It's a truly preventable public health crisis."

The British Heart Foundation, which part funded the research, said the findings highlight the urgent need for better screening.

The findings of the study have been published in the European Heart Journal.

AF is the most common type of irregular heartbeat. It causes the heart's chambers to beat in an uncoordinated, irregular manner.

The irregular rhythm can cause blood to pool in the heart, which can form into a blood clot. It this clot travels to the brain it can block the blood supply, leading to a stroke.

The researchers used national data collected between 2006 and 2016 to look at the numbers of patients who had been diagnosed with AF, whether patients at high-risk of a stroke had been given anticoagulants or clot-busting drugs, and the number of strokes that occurred.

They found that, since 2009, the number of people with AF who were being treated with anticoagulants had more than doubled.

The researchers estimate that, had the uptake of anticoagulants stayed at 2009 levels, there would have been around 4,000 more strokes in patients with AF in England in the 2015/16 financial year.

Stroke is the fourth biggest killer in the UK and the leading cause of disability and in 2016, killed almost twice as many women as breast cancer.

AF contributes to between 20 to 30 per cent of all strokes, and treating these patients with anticoagulants can cut patients' risk of stroke by two thirds.

The researchers say the increase in the use of clot-busting medicine is likely thanks to efforts across the health service to educate patients and doctors about the benefits of anticoagulation, changes to guidelines in the UK and Europe, and new types of anticoagulants which provide a safer and more convenient alternative to warfarin, which requires consistent monitoring and an added risk of major bleeds.

Worryingly, one in five AF diagnosed patients at a high-risk of a stroke are not currently taking anticoagulants.

The researchers warn that the study is based on data analysis with figures coming from a number of sources. They were unable to track individual patients. They also point out that the study shows an association, and cannot prove causation.

Professor Sir Nilesh Samani, Medical Director at the British Heart Foundation said: "This study demonstrates the real benefits to patients when research evidence is put into practice.

"The increased use of anticoagulants in with AF and the fall in the expected number of strokes is a major success story – but much more needs to be done.

"There are still half a million people in the UK with 'silent' AF, who have no idea they're at risk of having a stroke.

"Spotting AF can be surprisingly easy; often all it takes is a simple pulse check. A normal heart beat will feel regular, but if you find yours is irregular or random, go and see your GP. It could save your life."

Explore further: Patients who have had an irregular heart beat can't ever be considered 'cured'

More information: A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation. European Heart Journal,

Related Stories

Patients who have had an irregular heart beat can't ever be considered 'cured'

May 10, 2018
Patients with an abnormal heart rhythm that can leave them at a higher risk of suffering from stroke still need treatment even after their heart rhythm seems to have returned to normal, say researchers at the University of ...

Treatment gap in patients suffering from irregular heartbeat resulting in heightened risk of stroke

June 12, 2017
A study by the University of Birmingham has revealed a treatment gap in patients suffering from a heart condition that causes an irregular or abnormally fast heartbeat.

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Review of stroke treatment could save lives

September 30, 2011
Doctors are underutilising crucial medication to prevent deadly strokes in those with a common type of heart condition, new research says, leading to fresh calls for a review of current treatment strategies and more research ...

Blood thinners may raise stroke risk in over-65s with kidney disease

February 14, 2018
People over 65 years old may be increasing their stroke risk by taking anticoagulants for an irregular heartbeat if they also have chronic kidney disease, finds a new study led by UCL, St George's, University of London and ...

Greater burden of atrial fibrillation linked to higher stroke risk

May 16, 2018
Among people with intermittently recurring atrial fibrillation who are not taking anti-blood-clotting medications, those whose hearts were in abnormal rhythms longer were three times more likely to have strokes or other types ...

Recommended for you

Gut protein mutations shield against spikes in glucose

November 20, 2018
Why is it that, despite consuming the same number of calories, sodium and sugar, some people face little risk of diabetes or obesity while others are at higher risk? A new study by investigators at Brigham and Women's Hospital ...

Proteins cooperate to break up energy structures in oxygen starved heart cells

November 19, 2018
During a heart attack, the supply of oxygen to heart cells is decreased. This reduced oxygen level, called hypoxia, causes the cell's powerhouses, the mitochondria, to fragment, impairing cell function and leading to heart ...

Bullying and violence at work increases the risk of cardiovascular disease

November 19, 2018
People who are bullied at work or experience violence at work are at higher risk of heart and brain blood vessel problems, including heart attacks and stroke, according to the largest prospective study to investigate the ...

Genetic analysis links obesity with diabetes, coronary artery disease

November 16, 2018
A Cleveland Clinic genetic analysis has found that obesity itself, not just the adverse health effects associated with it, significantly increases the risk of Type 2 diabetes and coronary artery disease. The paper was published ...

Non-coding genetic variant could improve key vascular functions

November 15, 2018
Atherosclerotic disease, the slow and silent hardening and narrowing of the arteries, is a leading cause of mortality worldwide. It is responsible for more than 15 million deaths each year, including an estimated 610,000 ...

Study of two tribes sheds light on role of Western-influenced diet in blood pressure

November 14, 2018
A South American tribe living in near-total isolation with no Western dietary influences showed no increase in average blood pressure from age one to age 60, according to a study led by researchers at Johns Hopkins Bloomberg ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.